The United States spends nearly twice as much per capita on healthcare as any otherdeveloped nation, yet consistently ranks near the bottom on critical health outcomes, from lifeexpectancy to chronic disease burden. Americans pay more for hospital visits, physicianservices, and prescription drugs—not because care is more effective, but because the system isengineered to charge more. This contradiction is not incidental; it is systemic. The Iron Triangleof healthcare—cost, quality, and access—illustrates that optimizing one pillar often requirestrade-offs with the others. Yet the U.S. manages to compromise all three. In pursuit of profit, itdelivers a system that is simultaneously unaffordable, inaccessible, and often underperforming.Unlike nations with universal or public healthcare systems designed to promote populationhealth, the American model is fragmented, opaque, and driven by market logic. Insurancecompanies, pharmaceutical corporations, hospital networks, and medical device manufacturersall operate within a framework that rewards revenue generation over patient outcomes. Thispaper argues that the root cause of the nation's healthcare crisis is not inefficiency or lack ofinnovation—but a profit-centered architecture that treats health as a commodity. In such asystem, administrative complexity is rewarded, pricing is unregulated, and the human need forcare becomes subordinate to quarterly earnings. To build a just and sustainable healthcarefuture, we must confront a hard truth: profit and patient care do not—and cannot—share equalpriority.
Jocelyn Alvarez (Sat,) studied this question.